Wide areas of the pharmaceutical industry are ripe for enhancement, as examples from the industry’s top innovators reflect.

US President Donald Trump kicked off his second term with a series of directives aimed at the US National Institutes of ...

Aardvark’s lead candidate ARD-101 is being investigated in a Phase III study for hyperphagia in Prader-Willi syndrome.

Royalty Pharma has signed a deal to pay Biogen $250m to support the development of its late-stage experimental lupus ...

Speaking publicly for the first time about the USAID freeze, WHO director-general Dr Tedros has asked the US to reconsider ...

SmartCella has secured exclusive rights to advance research around cell replacement therapies for the treatment of ...

AbbVie has entered a partnership and option-to-license agreement with Xilio for tumour-activated, antibody-based ...

TriNetX has collaborated with Fujitsu to establish TriNetX Japan KK, a JV aimed at accelerating healthcare research and ...